Article ; Online: Emerging Role of the IL-36/IL-36R Axis in Multiple Inflammatory Skin Diseases.
The Journal of investigative dermatology
2024 Volume 144, Issue 2, Page(s) 206–224
Abstract: IL-36 is a most recent member of the IL-1 cytokine family, primarily expressed at barrier sites of the body such as the skin, lungs, and intestine. It plays a vital role in inflammation and is implicated in the development of various cutaneous; ... ...
Abstract | IL-36 is a most recent member of the IL-1 cytokine family, primarily expressed at barrier sites of the body such as the skin, lungs, and intestine. It plays a vital role in inflammation and is implicated in the development of various cutaneous; intestinal; and pulmonary disorders, including psoriasis, inflammatory bowel disease, and chronic obstructive pulmonary disease. IL-36 comprises 4 isoforms: the proinflammatory IL-36α, IL-36β, and IL-36γ and the anti-inflammatory IL-36R antagonist. An imbalance between proinflammatory and anti-inflammatory IL-36 isoforms can contribute to the inflammatory fate of cells and tissues. IL-36 cytokines signal through an IL-36R heterodimer mediating their function through canonical signaling cacade, including the NF-B pathway. Prominent for its role in psoriasis, IL-36 has recently been associated with disease mechanisms in atopic dermatitis, hidradenitis suppurativa, neutrophilic dermatoses, autoimmune blistering disease, and Netherton syndrome. The major cutaneous source of IL-36 cytokines is keratinocytes, pointing to its role in the communication between the epidermis, innate (neutrophils, dendritic cells) immune system, and adaptive (T helper [Th]1 cells, Th17) immune system. Thus, cutaneous IL-36 signaling is crucial for the immunopathological outcome of various skin diseases. Consequently, the IL-36/IL-36R axis has recently been recognized as a promising drug target for the treatment of inflammatory disorders beyond psoriasis. This review summarizes the current update on IL-36 cytokines in inflammatory skin diseases. |
---|---|
MeSH term(s) | Humans ; Anti-Inflammatory Agents ; Cytokines/metabolism ; Dermatitis ; Interleukin-1/metabolism ; Protein Isoforms ; Psoriasis ; Skin Diseases/drug therapy ; Skin Diseases/metabolism ; Receptors, Interleukin-1/metabolism |
Chemical Substances | Anti-Inflammatory Agents ; Cytokines ; Interleukin-1 ; Protein Isoforms ; IL36A protein, human ; IL36B protein, human ; IL36RN protein, human ; Receptors, Interleukin-1 |
Language | English |
Publishing date | 2024-01-07 |
Publishing country | United States |
Document type | Journal Article ; Review |
ZDB-ID | 80136-7 |
ISSN | 1523-1747 ; 0022-202X |
ISSN (online) | 1523-1747 |
ISSN | 0022-202X |
DOI | 10.1016/j.jid.2023.11.004 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Ui VI Zs.124: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.